-
Mashup Score: 02024 SITC Election | Vice President | At-Large Directors - 4 hour(s) ago
The 2024 SITC Election will take place May 2–16, 2024. SITC regular or emertius members eligible to vote and help choose the future leaders of the society.
Source: www.sitcancer.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 7
Chelsey Gomez: Cancer survivorship comes with so many complex feelings / cancer, cancer survivorship, Chelsey Gomez, LMICs, Nirmala Bhoo Pathy,
Source: oncodaily.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 45Seattle, WA: Petros Grivas - Bladder Cancer Advocacy Network - 7 day(s) ago
Contact Us: 4520 East West Highway, Suite 610 Bethesda, Maryland 20814 Phone: (301) 215-9099 Fax: (973) 215-9092 info@bcan.org © 2024 Bladder Cancer Advocacy Network. All Rights
Source: secure2.convio.netCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 72
Patients with Bacillus Calmette–Guérin (BCG)–unresponsive non–muscle-invasive bladder cancer (NMIBC) have limited treatment options. The immune cell–activating interleukin-15 (IL-15) superagonist N…
Source: evidence.nejm.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 36PeerView - Maximizing the Role of ADCs in Urothelial Carcinoma: Practical Tips for Patient Selection, Safety Management, and Collaborative Care - 10 day(s) ago
See the latest #BladderCancer live event from @PeerView @PGrivasMDPhD #ASCO24 #MedEd
Source: lrn.peerview.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1
Petros Grivas: Trial is open and we look for more sites! / cancer, chemotherapy, Durvalumab, EA8192, ECOG-ACRIN Cancer Research Group, Fred Hutchinson Cancer
Source: oncodaily.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 8Home - 19 day(s) ago
Thank you! Your subscription has been confirmed. You’ll hear from us
Source: apccc.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 8Home - 21 day(s) ago
Thank you! Your subscription has been confirmed. You’ll hear from us
Source: apccc.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 8Home - 21 day(s) ago
Thank you! Your subscription has been confirmed. You’ll hear from us
Source: apccc.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 6First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors - 26 day(s) ago
This first-in-human study was conducted to characterize the safety, tolerability, pharmacokinetics, and preliminary efficacy of single-agent tinengotinib i
Source: academic.oup.comCategories: General Medicine News, Partners & KOLsTweet
Fantastic to see brilliant Larry Fong with huge contributions soon joining @fredhutch & @HaanenJohn et al. in ballot @sitcancer consider voting for #SITC elections: https://t.co/P3PM9oQBWd @BhatiaS_MD @OncoAlert @EvanHallMD @UroDocAsh @MattGalsky @RahulBanerjeeMD @NamrataRheum